MedPath

Clinical Study of Stent Versus Direct Atherectomy to Treat Arteriosclerosis Occlusive Disease of Lower Extremity

Not Applicable
Completed
Conditions
Ischemia
Atherosclerosis
Registration Number
NCT02840786
Lead Sponsor
Xuanwu Hospital, Beijing
Brief Summary

This is a randomized study comparing stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery)

Detailed Description

This is a randomized study comparing balloon angioplasty adjunctive stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
221
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
12-month Primary Patency Rate12 months

systolic velocity ratio \>2.4 as measured by Duplex ultrasound.

Secondary Outcome Measures
NameTimeMethod
Technical success1 day

Technical success was defined as residual stenosis less than 30% by final angiography and/or a flow-limiting dissection.

freedom from clinically-driven TLR12 months

it is defined as thefreedom from clinically-driven target lesion revascularization

Major Adverse Events at 12-month Post Procedure12 months

Major adverse events included death, index limb ischemia, index limb amputation, clinically driven target lesion revascularization , and significant embolic events, which were defined as causing end-organ damage.

12-month Limb Salvage Rate12 months

Limb Salvage is defined as the freedom from secondary major amputation

Trial Locations

Locations (1)

Gu Yong Quan

🇨🇳

Beijing, Beijing, China

Gu Yong Quan
🇨🇳Beijing, Beijing, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.